Bellerophon Therapeutics
BLPH
#11324
Rank
โ‚น13.6 M
Marketcap
โ‚น1.11
Share price
-36.84%
Change (1 day)
-79.05%
Change (1 year)

EPS for Bellerophon Therapeutics (BLPH)

EPS in 2023 (TTM): -โ‚น68.73

According to Bellerophon Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น77.84. In 2017 the company made an earnings per share (EPS) of -โ‚น1,918 an increase over its 2016 EPS that were of -โ‚น2,224.

EPS history for Bellerophon Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น68.73
2017-โ‚น1,918-13.75%
2016-โ‚น2,224

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
โ‚น250.57-421.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น130.66 67.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Lantheus Holdings
LNTH
โ‚น383.65-592.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
โ‚น122.32-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA